Heerka digniinta kambasku waa cagaar: Si aad u heshid heerka digniinta xarunta UMMS ee ugu dambeysay, wararka iyo agabka, fadlan booqo umassmed.edu/coronavirus
Iyada oo qayb ka ah machadyada Qaranka ee barnaamijka dardargelinta ogaanshaha degdegga ah (RADx), daraasad dheer oo ay si wada jir ah u qoreen cilmi-baarayaal ka socda Jaamacadda Massachusetts Medical School ayaa sheegay in tijaabada PCR iyo baaritaanka antigen-ka degdegga ah ee SARS-CoV-2 ay faa'iido u leeyihiin ogaanshaha Infekshannada Si la mid ah ayay waxtar u leedahay.Sii ugu yaraan laba jeer toddobaadkii.
Sida laga soo xigtay war-saxaafadeedka NIH, inkasta oo baaritaanka shakhsi ahaaneed ee PCR loo tixgeliyo heerka dahabka, haddana way ka xasaasisan tahay baaritaanka antigen-ka, gaar ahaan marxaladaha hore ee caabuqa, laakiin natiijooyinka ayaa muujinaya in marka si joogto ah loo sameeyo iyada oo qayb ka ah barnaamijka baaritaanka, labada hababka tijaabinta ayaa aad xasaasi u ah.Dareenka ayaa gaari kara 98%.Tani waa war wanaagsan oo loogu talagalay barnaamijyada ka hortagga ballaaran, sababtoo ah baaritaanka antigen-ka ee goobta daryeelka ama guriga waxay ku siin kartaa natiijooyin degdeg ah iyada oo aan la qorin oo ka qaalisan baaritaanka shaybaarka.
Cilmi-baarista waxaa lagu daabacay "Journal of Infectious Diseases" bishii Juun 30. Cilmi-baarayaal ka socda Jaamacadda Illinois ee Urbana-Champaign, Johns Hopkins School of Medicine, iyo Machadka Qaranka ee Imaging Biomedical iyo Bioengineering oo qoray warqadan waa: Associate Professor ee Daawada Laura L. · Gibson (Laura L. Gibson);Alyssa N. Owens, Ph.D., Iskuduwaha Cilmi-baarista;John P. Broach, MD, MBA, MBA, Kaaliyaha Professor ee Daawada Degdegga ah;Bruce A. Barton, PhD, Dadweynaha iyo Bare-sare ee Sayniska Caafimaadka Tirada;Peter Lazar, horumarinta xogta macluumaadka codsiga;iyo David D. McManus, MD, Richard M. Haidack Professor of Medicine, Guddoomiyaha Daawada iyo Professor.
Dr. Bruce Tromberg, Agaasimaha NIBIB, oo hoos timaada NIH, ayaa yiri: "Ku samaynta baaritaanka antigen-ka degdega ah guriga laba ilaa saddex jeer usbuucii waa hab awood leh oo ku habboon shakhsiyaadka si ay uga baaraan cudurka COVID-19."Markii dib loo furay iskuullada iyo ganacsiyada, khatarta caabuqa shakhsi ahaaneed ayaa laga yaabaa inay isbedesho maalin kasta.Baaritaanka joogtada ah ee antigen-ku wuxuu dadka ka caawin karaa inay maareeyaan khatartan oo ay si dhakhso ah u dhaqmaan si looga hortago fiditaanka fayraska."
Cilmi baadhayaashu waxay soo ururiyeen laba nooc oo sanka suufka iyo candhuufta laga qaado shaqaalaha iyo ardayda ka qayb qaadanaya intii lagu jiray barnaamijka baadhista COVID-19 ee Jaamacadda Illinois ee Urbana-Champaign 14 maalmood oo isku xigta.Mid ka mid ah suufka sanka ee ka qaybgale kasta ayaa loo diray shaybaadhka jaamacadda Johns Hopkins si uu u eego koritaanka fayraska nool ee dhaqanka iyo in qiyaas ahaan loo cabbiro wakhtiga uu maadada u gudbin karo caabuqa dadka kale.
Cilmi-baarayaashu waxay markaa is barbar dhigeen saddex hab oo lagu ogaanayo COVID-19: baaritaanka PCR candhuufta, tijaabada PCR ee sanka, iyo muunadda sanka ee tijaabada antigen-ka degdega ah.Waxay xisaabiyeen dareenka hab kasta oo tijaabo ah si loo ogaado SARS-CoV-2 waxayna cabbireen joogitaanka fayraska nool laba toddobaad gudahooda ee caabuqa.
Markii ay cilmi-baarayaashu xisaabiyeen dareenka tijaabada ee ku salaysan hab-socodka tijaabada saddexdii maalmoodba mar, waxay sheegeen in haddii ay isticmaaleen baaritaanka antigen-ka degdegga ah ama baaritaanka PCR, dareenka ogaanshaha caabuqa uu ka sarreeyay 98%.Markay kaliya qiimeeyeen inta jeer ee la ogaado todobaadkiiba hal mar, dareenka PCR ee lagu ogaanayo sanka iyo candhuufta ayaa weli sarreeya, qiyaastii 98%, laakiin dareenka ogaanshaha antigen-ka ayaa hoos ugu dhacay 80%.
"Caqabadda ku jirta tarjumaadda PCR ama natiijooyinka baaritaanka antigen-ka ayaa ah in baaritaanka togan uusan muujin karin jiritaanka caabuqa faafa (gaar ahaan hoose) ama laga yaabo inuusan ku ogaanin fayraska nool ee muunada (dareen hoose), siday u kala horreeyaan," ayuu yiri hogaamiyaha la-taliyaha Dr. Gibson.RADx Tech xudunta cilmi baarista kiliinikada.
"Cilmiga cilmi-baaristan ayaa ah inaan ku lammaaneyno PCR iyo ogaanshaha antigen-ka iyo dhaqanka fayraska sida calaamad caabuq ah.Nakhshad cilmi-baaristu waxay daaha ka qaadaysaa habka ugu wanaagsan ee loo isticmaalo nooc kasta oo tijaabo ah, waxayna yaraynaysaa halista laga shakisan yahay COVID-19 Bukaanku wuxuu sharxayaa saamaynta caqabadda natiijooyinkooda."
Dr. Nathaniel Hafer, kaaliyaha borofisar ee daawada molecular iyo maamulaha baaraha RADx Tech Study Logistics Core, ayaa yiri: "Tusaale ahaan saameynta shaqadeena, xogta aan aruurineyno waxay caawisaa bixinta CDC macluumaadka ku saabsan dadyow kala duwan."
Dr. Hafer wuxuu tilmaamay doorka muhiimka ah ee Dugsiga Caafimaadka ee UMass ee naqshadeynta, hirgelinta iyo falanqaynta imtixaanka xasaasiga ah.Waxa uu si gaar ah u ammaanay kooxda cilmi-baarista ee Jaamacadda Massachusetts Medical School oo uu hoggaamiyo Dr. Broach, oo ay ku jiraan agaasimaha mashruuca Gul Nowshad iyo navigator Bernadette Shaw-doorka ay ka qaateen meel fog ka-qaybgalayaasha daraasadda ee qolka jiifka Door muhiim ah Jaamacadda ee Illinois.
Warbixin la xidhiidha oo ka timid UMassMed News: Intii lagu guda jiray booqashadii Congress-ka ee xerada NIH, hindisaha RADx ayaa xoogga la saaray.Dugsiga Caafimaadka UMass wuxuu caawiyaa hogaaminta NIH RADx si loo dardargeliyo tignoolajiyada cusub ee tijaabada COVID.Ciwaanka wararka: Dugsiga Caafimaadka UMass wuxuu helay $100 milyan oo deeq NIH ah si kor loogu qaado baarista COVID-19 degdeg ah, la heli karo
Questions or comments? Email: UMMSCommunications@umassmed.edu Tel: 508-856-2000 • 508-856-3797 (fax)
Waqtiga boostada: Jul-14-2021